These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1575 related items for PubMed ID: 19035499

  • 1. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL.
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [Abstract] [Full Text] [Related]

  • 2. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A.
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [Abstract] [Full Text] [Related]

  • 3. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.
    Camargo CZ, Sekiyama JY, Arismendi MI, Kayser C.
    Scand J Rheumatol; 2015 Jun; 44(1):48-55. PubMed ID: 25379977
    [Abstract] [Full Text] [Related]

  • 4. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D, Grodzicky T, Senécal JL.
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [Abstract] [Full Text] [Related]

  • 5. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y.
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.
    Rajkumar VS, Sundberg C, Abraham DJ, Rubin K, Black CM.
    Arthritis Rheum; 1999 May; 42(5):930-41. PubMed ID: 10323448
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P, Yarom A, Davis E.
    J Mal Vasc; 1992 May; 17(4):273-6. PubMed ID: 1494054
    [Abstract] [Full Text] [Related]

  • 14. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome.
    Statham BN, Rowell NR.
    Acta Derm Venereol; 1986 May; 66(2):139-43. PubMed ID: 2424237
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Juvenile systemic sclerosis: a follow-up study of eight patients.
    Szamosi S, Maródi L, Czirják L, Ellenes Z, Szücs G.
    Ann N Y Acad Sci; 2005 Jun; 1051():229-34. PubMed ID: 16126963
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.